 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the launch of updated t:slim X2 insulin pump software with Dexcom G7 Continuous...

Tandem Diabetes Care Launches t:slim X2 Insulin Pump Software with Dexcom G7 CGM Integration in U.S.

Great West Life Assurance Co. Can decreased its position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM  Free Report) by 1.2% in the second quarter, according to its most recent 13F filing with...

Great West Life Assurance Co. Can Sells 942 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)

Champlain Investment Partners LLC trimmed its position in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM  Free Report) by 50.5% during the 2nd quarter, according to its most recent 13F...

Champlain Investment Partners LLC Sells 1,654,393 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)

American International Group Inc. decreased its position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM  Free Report) by 15.0% in the 2nd quarter, according to the company in its most recent 13F...

American International Group Inc. Sells 748 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)

This price move could indicate a change in the trend, and may be a buy signal for investors...

Tandem Diabetes Care (TNDM, $19.04) price moved above its 50-day Moving Average on November 22, 2023

For the last three days, A.I.dvisor has detected that TNDM's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Tandem Diabetes Care (TNDM, $18.4) Aroon Indicator entered a Downtrend on November 21, 2023.

Tandem Diabetes Care (TNDM, $17.79) Aroon Indicator entered a Downtrend on November 17, 2023.

This is a signal that TNDM's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...

Tandem Diabetes Care (TNDM, $18.41) Stochastic Oscillator left the overbought zone on November 16, 2023

Increase Prevalence of Diabetic Patients Driving Market Growth Projected to Reach $55 Billion by 2029 Increase Prevalence of Diabetic Patients Driving Market Growth Projected to Reach $55 Billion by...

Increase Prevalence of Diabetic Patients Driving Market Growth Projected to Reach $55 Billion by 2029

This indicator may be signaling TNDM's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Tandem Diabetes Care (TNDM, $17.82) entered Uptrend as Momentum indicator ascends above 0 level on Nov 14, 2023

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M. DiPerna on January 27, 2006, and is headquartered in San Diego, CA.

Market Cap	$1.45B
Volume (M)	1.58M
52-Wk High	$47.18
52-Wk Low	$13.82

Current Price	$22.23
Prev Close	$21.16
Open	$21.54
Dividend Yield	0.00%
50-Day Moving Average	$18.54
Beta	1.36
Avg. Volume	1.88M
PE Ratio	-6.90

52-Week High	$47.18
52-Week Low	$13.82
Market Capitalization	$1.45B
EPS	-$3.22
Price to Book	4.62
Revenue Per Employee	$296,701.54
Enterprise Value/EBITDA	-10.44

TNDM Tandem Diabetes Care Inc

About

Feed

News

Sentiment

Earnings

Fundamentals